Medicamen Biotech Share Price
09 Nov, 2026 3:51 PM (IST)
Medicamen Biotech Performance
- Today's Low
- ₹276
- Today's High
- ₹287
- 52 Week Low
- ₹212
- 52 Week High
- ₹448
- Open Price₹284
- Previous Close₹281
- Volume3,608
- 50 DMA₹278.00
- 100 DMA₹275.60
- 200 DMA₹288.40
Medicamen Biotech Chart
Investment Returns
- Over 1 Month -7.08%
- Over 3 Month + 18.61%
- Over 6 Month -5.01%
- Over 1 Year -31.1%
Smart Investing Starts Here Start SIP with Medicamen Biotech for Steady Growth!
Medicamen Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 36.3
- PEG Ratio
- 1.7
- Market Cap Cr
- 393
- P/B Ratio
- 1.4
- Average True Range
- 14.7
- EPS
- 7.7
- Dividend Yield
- 0.4
- MACD Signal
- -5.3
- RSI
- 51.77
- MFI
- 53.2
Latest Stock News Updates
Certificate under Regulation 74 (5) of SEBI (DP) Regulation 2018- September 30, 2026
- BSE India
- 2 weeks 1 day ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd
- BSE India
- 2 weeks 1 day ago
Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to conversion of 5,00,000 fully convertible warrants at an issue price of Rs. 530/- per Equity Share
- BSE India
- 2 weeks 4 days ago
Medicamen Biotech Financials
Medicamen Biotech Technicals
EMA & SMA
- Bearish Moving Average 3
- Bullish Moving Average 13
- 20 Day
- ₹274.40
- 50 Day
- ₹278.00
- 100 Day
- ₹275.60
- 200 Day
- ₹288.40
Resistance and Support
- R3 297.10
- R2 292.00
- R1 285.80
- S1 274.50
- S2 269.40
- S3 263.20
Medicamen Biotech Corporate Actions - Bonus, Splits, Dividends
About Medicamen Biotech
Medicamen Biotech engaged in the research, development and manufacturing, and global marketing of Finished Dosage Forms (FDFs) and liquid formulations. MBL specializes in Oncology, Cardiovascular Diseases (CVD), Central Nervous System (CNS), Diabetology, Anti-Malarials, Antibiotics and Pain Managemen with an established presence across more than 35 countries in the Rest of the World (ROW) and an expanding footprint in highly regulated markets, View More- NSE Symbol
- MEDICAMEQ
- BSE Symbol
- 531146
- ISIN
- INE646B01010
Similar Stocks to Medicamen Biotech
Popular Stocks
Medicamen Biotech FAQs
Medicamen Biotech share price is ₹279 As on 10 November, 2026 | 20:36
The Market Cap of Medicamen Biotech is ₹393.1 Cr As on 10 November, 2026 | 20:36
The P/E ratio of Medicamen Biotech is 36.3 As on 10 November, 2026 | 20:36
The PB ratio of Medicamen Biotech is 1.4 As on 10 November, 2026 | 20:36
The 52 week High & Low of Medicamen Biotech is ₹447.6/₹212.4 respectively As on 10 November, 2026 | 20:36
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.